Search
for
Sort by
Research 121–150 of 1000+
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Increase in IL-15 levels in patients with alopecia areata
- Noval advance of histone modification in inflammatory skin diseases and related treatment methods
- Vitamin D and the skin: Focus on a complex relationship: A review
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- Differential impact of environmental factors on systemic and localized autoimmunity
- Early prediction of alopecia areata using machine learning modeling of neuro stress immune signatures from multi datasets
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- The Use of 308-nm Excimer Laser Therapy in Alopecia Areata and Primary Cicatricial Alopecia: A Systematic Review
- Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis
- Immune therapies for alopecia areata: evidence and new perspectives
- Selective Expression of Chemokine Monokine Induced by Interferon-γ in Alopecia Areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Gene Expression of CD70 and CD27 Is Increased in Alopecia Areata Lesions and Associated with Disease Severity and Activity
- Vaccines, adjuvants and autoimmunity
- Dietary Habits in Japanese Patients with Alopecia Areata
- Immunology of alopecia areata
- Genetic Insights into Acne, Androgenetic Alopecia, and Alopecia Areata: Implications for Mechanisms and Precision Dermatology
- Tertiary Lymphoid Organs at the Center Stage of Skin's Humoral Immunity
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Review of Promising Off-Label Use of Deucravacitinib
- Chronic graft versus host disease and skin
- Diabetes mellitus: interdisciplinary medical, surgical and psychological therapeutic approach
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Volatile organic compounds: A proinflammatory activator in autoimmune diseases
- Cytokine Engineering Approaches for Regenerative Medicine
- JAK inhibition decreases the autoimmune burden in Down syndrome